The Manual on Viruses

There is currently NO
antiviral drug (vaccionation)
to treat EVD in people.
When used early,
basic interventions can
significantly improve the
chances of survival.
Drugs that are being
developed to treat EVD work
by stopping the virus from
making copies of itself.
There has been the rVSV-ZEBOV vaccine that was
sudied in trial involving 11 841 people. Among the
5837 people who recieved the vaccine, no Ebola
cases were recorde 10 days or more after vaccination.
In comparison, there were 23 cases 10 days or
more after vaccination amonge those who did not
recieved the vaccine.
THE MANUAL ON VIRUSES
// 43